Orion Pharma Limited reported earnings results for the third quarter and nine months ended March 31, 2023. For the third quarter, the company reported sales was BDT 2,297.65 million compared to BDT 1,137.88 million a year ago. Net income was BDT 123.87 million compared to BDT 245.45 million a year ago. Basic earnings per share from continuing operations was BDT 0.53 compared to BDT 1.05 a year ago.
For the nine months, sales was BDT 10,210.82 million compared to BDT 3,079.93 million a year ago. Net income was BDT 571.62 million compared to BDT 718.05 million a year ago. Basic earnings per share from continuing operations was BDT 2.44 compared to BDT 3.07 a year ago.